Acute Kidney Injury Clinical Trial
Official title:
Critical Illness Myopathy and Trajectory of Recovery in Acute Kidney Injury (AKI) Requiring Continuous Renal Replacement Therapy (CRRT): A Prospective Observational Trial
Verified date | March 2024 |
Source | University of Iowa |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
The purpose of this study is to determine whether patients with acute kidney injury requiring renal replacement therapy have a higher incidence of muscle wasting than controls and whether the course of recovery is longer compared to controls.
Status | Active, not recruiting |
Enrollment | 10 |
Est. completion date | December 30, 2024 |
Est. primary completion date | September 30, 2023 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 89 Years |
Eligibility | Inclusion Criteria: - >18 years old - AKI requiring CRRT, with enrollment within 48 hours of CRRT initiation Exclusion Criteria: - ICU admission for >7 days - RRT of any kind at any time prior to ICU admission - Chronic kidney disease (CKD) with estimated glomerular filtration rate <20 mL/min/1.73 m2 as calculated by the 2021 CKD-EPI equation - underlying muscle disorders or muscle atrophy such as quadriplegia or hemiplegia, stroke with residual motor deficits, end-stage liver disease, active alcohol use disorder, active malignancy (other than non-melanoma skin cancer) within 1 year, burns, or other baseline neuromuscular disease - pregnancy - concomitant use of other extracorporeal support devices such as ventricular assist devices or extracorporeal membrane oxygenation - anticipated inability to engage in weight-bearing testing after discharge (e.g., trauma or orthopedic surgery) - subjects will be ineligible for outpatient testing if they remain on RRT in the week prior to the research appointment |
Country | Name | City | State |
---|---|---|---|
United States | University of New Mexico | Albuquerque | New Mexico |
United States | University of Iowa | Iowa City | Iowa |
United States | University of Kentucky | Lexington | Kentucky |
Lead Sponsor | Collaborator |
---|---|
University of Iowa |
United States,
Mayer KP, Dhar S, Cassity E, Denham A, England J, Morris PE, Dupont-Versteegden EE. Interrater Reliability of Muscle Ultrasonography Image Acquisition by Physical Therapists in Patients Who Have or Who Survived Critical Illness. Phys Ther. 2020 Aug 31;100(9):1701-1711. doi: 10.1093/ptj/pzaa068. — View Citation
Mayer KP, Ortiz-Soriano VM, Kalantar A, Lambert J, Morris PE, Neyra JA. Acute kidney injury contributes to worse physical and quality of life outcomes in survivors of critical illness. BMC Nephrol. 2022 Apr 7;23(1):137. doi: 10.1186/s12882-022-02749-z. — View Citation
Mayer KP, Thompson Bastin ML, Montgomery-Yates AA, Pastva AM, Dupont-Versteegden EE, Parry SM, Morris PE. Acute skeletal muscle wasting and dysfunction predict physical disability at hospital discharge in patients with critical illness. Crit Care. 2020 Nov 4;24(1):637. doi: 10.1186/s13054-020-03355-x. — View Citation
Mayer KP, Welle MM, Evans CG, Greenhill BG, Montgomery-Yates AA, Dupont-Versteegden EE, Morris PE, Parry SM. Muscle Power is Related to Physical Function in Patients Surviving Acute Respiratory Failure: A Prospective Observational Study. Am J Med Sci. 2021 Mar;361(3):310-318. doi: 10.1016/j.amjms.2020.09.018. Epub 2020 Oct 3. — View Citation
Teixeira JP, Mayer KP, Griffin BR, George N, Jenkins N, Pal CA, Gonzalez-Seguel F, Neyra JA. Intensive Care Unit-Acquired Weakness in Patients With Acute Kidney Injury: A Contemporary Review. Am J Kidney Dis. 2023 Mar;81(3):336-351. doi: 10.1053/j.ajkd.2022.08.028. Epub 2022 Nov 2. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | ICU Stage: rectus femoris (RF) cross-sectional area (CSA) | RF CSA as assessed by musculoskeletal ultrasound (MSKUS) will be measured at day 0 (study enrollment within 48 hours of CRRT initiation), at day 3, and at day 7 (or at ICU discharge if before day 7). | 7 days | |
Primary | ICU Stage: RF muscle thickness (mT) | RF mT as assessed by MSKUS will be measured at day 0 (study enrollment within 48 hours of CRRT initiation), at day 3, and at day 7 (or at ICU discharge if before day 7). | 7 days | |
Primary | ICU Stage: RF echo intensity (EI) | RF EI as assessed by MSKUS will be measured at day 0 (study enrollment within 48 hours of CRRT initiation), at day 3, and at day 7 (or at ICU discharge if before day 7). | 7 days | |
Primary | RF CSA at discharge | RF CSA as assessed by MSKUS will be measured at hospital discharge. | 1 month | |
Primary | RF mT at discharge | RF mT as assessed by MSKUS will be measured at hospital discharge. | 1 month | |
Primary | RF EI at discharge | RF EI as assessed by MSKUS will be measured at hospital discharge. | 1 month | |
Primary | RF CSA at post-discharge outpatient visit | RF CSA as assessed by MSKUS will be measured at outpatient follow-up visit. | 1-3 months | |
Primary | RF mT at post-discharge outpatient visit | RF mT as assessed by MSKUS will be measured at outpatient follow-up visit. | 1-3 months | |
Primary | RF EI at post-discharge outpatient visit | RF mT as assessed by MSKUS will be measured at outpatient follow-up visit. | 1-3 months | |
Primary | ICU Stage: ICU Mobility Scale | The ICU Mobility Scale is an 11-point scale ranging from 0-10 which involves scoring a patient's maximum level of mobility in the prior 24-hour period. The ICU Mobility Scale will be performed at the same 3 time points as the MSKUS assessments. | 7 days | |
Primary | Muscle Strength - Medical Research Council Sum-score (MRC-ss) at discharge | MRC-ss is a measure of global peripheral muscle strength that is the current clinical standard for diagnosing ICU-acquired weakness. Muscle strength is assessed by physical exam and rated on an ordinal scale (0-5) at six bilateral muscle groups: shoulder abductors, elbow flexors, wrist extensors, hip flexors, knee extensors, and ankle dorsiflexors. | 1 month | |
Primary | Muscle Strength - MRC-ss at post-discharge outpatient visit | MRC-ss is a measure of global peripheral muscle strength that is the current clinical standard for diagnosing ICU-acquired weakness. Muscle strength is assessed by physical exam and rated on an ordinal scale (0-5) at six bilateral muscle groups: shoulder abductors, elbow flexors, wrist extensors, hip flexors, knee extensors, and ankle dorsiflexors. | 1-3 months | |
Primary | Muscle Strength - knee extension by hand-held dynamometry (HHD) at hospital discharge | Maximal isometric knee extensor muscle strength as measured by HHD. | 1 month | |
Primary | Muscle Strength - knee extension by HHD at post-discharge outpatient visit | Maximal isometric knee extensor muscle strength as measured by HHD. | 1-3 months | |
Primary | Muscle Strength - Grip Strength at hospital discharge | Maximal isometric grip strength as measured by hand-grip dynamometry (HGD) | 1 month | |
Primary | Muscle Strength - Grip Strength at post-discharge outpatient visit | Maximal isometric grip strength as measured by HGD | 1-3 months | |
Primary | Physical Function - Short Physical Performance Battery (SPPB) at discharge | SPPB is a performance-based composite test with a total of 12 points including components of balance (side-by-side stand, semi-tandem stand, and full-tandem stand), chair-to-stand test, and 4-meter habitual gait speed used to assess physical function and physical frailty. | 1 month | |
Primary | Physical Function - SPPB at post-discharge outpatient visit | SPPB is a performance-based composite test with a total of 12 points including components of balance (side-by-side stand, semi-tandem stand, and full-tandem stand), chair-to-stand test, and 4-meter habitual gait speed used to assess physical function and physical frailty. | 1-3 months | |
Primary | TUG Test at post-discharge outpatient visit | The Timed Up and Go (TUG) test assesses the time (in seconds) for a subject to stand on command from a seated position, walk 3 meters, turn around, walk back to the chair, and sit down, thereby assessing mobility, physical function, and fall risk. | 1-3 months | |
Primary | Physical Function - 6-minute walk test (6MWT) at post-discharge outpatient visit | The 6MWT assesses the distance a subject can walk in six minutes, providing a global representation of physical function and cardiopulmonary endurance. | 1-3 months | |
Primary | Quality of Life testing using EuroQol Group 5-dimension 5-level (EQ-5D-5L) questionnaire at post-discharge outpatient visit | The EQ-5D-5L is a standardized measure of health status developed by the Euro-Qol Group to provide an assessment of health for clinical and economic appraisal. | 1-3 months | |
Primary | Physical Function - Clinical Frailty Scale (CFS) at post-discharge outpatient visit | CFS is a widely adopted judgement-based tool to screen for frailty and to broadly stratify degrees of fitness and frailty. | 1-3 months | |
Primary | Functional Assessment of Chronic Illness Therapy Fatigue (FACIT-F) Questionnaire at post-discharge outpatient visit | The FACIT-F scale is a 13-item measure that assesses self-reported fatigue and its impact upon daily activities and function. | 1-3 months | |
Primary | 36-Item Short Form Health Survey Physical Function Scale (SF-36) at post-discharge outpatient visit | The SF-36 is a 36-item patient-reported survey of health commonly used to evaluate adult patients which contains 8 domains, including a physical function scale based on 10 of the 36 items which has been shown to have high reliability. | 1-3 months | |
Primary | Return to driving | Yes / No outcome assessed at the outpatient follow-up visit | 1-3 months | |
Primary | Return to work or hobby | Yes / No outcome assessed at the outpatient follow-up visit | 1-3 months | |
Primary | Hospital Readmission | Yes / No outcome assessed at the outpatient follow-up visit | 1-3 months | |
Primary | Emergency Department Visit | Yes / No outcome assessed at the outpatient follow-up visit | 1-3 months | |
Secondary | ICU Stage: Changes in Plasma Metabolome | Plasma samples will be obtained at day 0 (study enrollment within 48 hours of CRRT initiation), at day 3, and at day 7 (or at ICU discharge if before day 7) and metabolomic analysis will be performed to determine if changes in the plasma metabolome with CRRT initiation correlate with parameters of muscle wasting and/or trajectory of recovery of muscle weakness. | 7 days | |
Secondary | ICU Stage: Changes in CRRT Effluent Metabolome | CRRT effluent samples will be obtained at day 0 (study enrollment within 48 hours of CRRT initiation), at day 3, and at day 7 (or at ICU discharge if before day 7) and metabolomic analysis will be performed to determine if changes in the effluent metabolome with CRRT initiation correlate with parameters of muscle wasting and/or trajectory of recovery of muscle weakness. | 7 days |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05538351 -
A Study to Support the Development of the Enhanced Fluid Assessment Tool for Patients With Acute Kidney Injury
|
||
Recruiting |
NCT06027788 -
CTSN Embolic Protection Trial
|
N/A | |
Completed |
NCT03938038 -
Guidance of Ultrasound in Intensive Care to Direct Euvolemia
|
N/A | |
Recruiting |
NCT05805709 -
A Patient-centered Trial of a Process-of-care Intervention in Hospitalized AKI Patients: the COPE-AKI Trial
|
N/A | |
Recruiting |
NCT05318196 -
Molecular Prediction of Development, Progression or Complications of Kidney, Immune or Transplantation-related Diseases
|
||
Recruiting |
NCT05897840 -
Continuous Central Venous Oxygen Saturation Measurement as a Tool to Predict Hemodynamic Instability Related to Renal Replacement Therapy in Critically Ill Patients
|
N/A | |
Recruiting |
NCT04986137 -
Fractional Excretion of Urea for the Differential Diagnosis of Acute Kidney Injury in Cirrhosis
|
||
Terminated |
NCT04293744 -
Acute Kidney Injury After Cardiac Surgery
|
N/A | |
Completed |
NCT04095143 -
Ultrasound Markers of Organ Congestion in Severe Acute Kidney Injury
|
||
Not yet recruiting |
NCT06026592 -
Detection of Plasma DNA of Renal Origin in Kidney Transplant Patients
|
||
Not yet recruiting |
NCT06064305 -
Transcriptional and Proteomic Analysis of Acute Kidney Injury
|
||
Terminated |
NCT03438877 -
Intensive Versus Regular Dosage For PD In AKI.
|
N/A | |
Terminated |
NCT03305549 -
Recovery After Dialysis-Requiring Acute Kidney Injury
|
N/A | |
Completed |
NCT05990660 -
Renal Assist Device (RAD) for Patients With Renal Insufficiency Undergoing Cardiac Surgery
|
N/A | |
Completed |
NCT04062994 -
A Clinical Decision Support Trial to Reduce Intraoperative Hypotension
|
||
Terminated |
NCT02860130 -
Clinical Evaluation of Use of Prismocitrate 18 in Patients Undergoing Acute Continuous Renal Replacement Therapy (CRRT)
|
Phase 3 | |
Completed |
NCT06000098 -
Consol Time and Acute Kidney Injury in Robotic-assisted Prostatectomy
|
||
Not yet recruiting |
NCT05548725 -
Relation Between Acute Kidney Injury and Mineral Bone Disease
|
||
Completed |
NCT02665377 -
Prevention of Akute Kidney Injury, Hearttransplant, ANP
|
Phase 3 | |
Terminated |
NCT03539861 -
Immunomodulatory Biomimetic Device to Treat Myocardial Stunning in End-stage Renal Disease Patients
|
N/A |